EA201170555A1 - Эмульсии с модифицированным высвобождением для нанесения на кожные покровы или слизистую влагалища - Google Patents
Эмульсии с модифицированным высвобождением для нанесения на кожные покровы или слизистую влагалищаInfo
- Publication number
- EA201170555A1 EA201170555A1 EA201170555A EA201170555A EA201170555A1 EA 201170555 A1 EA201170555 A1 EA 201170555A1 EA 201170555 A EA201170555 A EA 201170555A EA 201170555 A EA201170555 A EA 201170555A EA 201170555 A1 EA201170555 A1 EA 201170555A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- emulsions
- slim
- visual
- application
- modified release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/345—Nitrofurans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pregnancy & Childbirth (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Colloid Chemistry (AREA)
Abstract
Эмульсии масло-в-воде с модифицированным высвобождением, применяемые для доставки лекарственных веществ в пораженные участки тканей. Эмульсии в соответствии с заявленным изобретением содержат липофильный активный ингредиент, полностью растворенный в гидрофобной внутренней фазе, стабилизированной при помощи полимерного сурфактанта. Присутствие данного полимера вокруг гидрофобных частиц позволяет избежать миграции активного ингредиента во внешнюю гидрофильную фазу и, следовательно, его рекристаллизации.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08166058A EP2174650A1 (en) | 2008-10-08 | 2008-10-08 | Modified release emulsions for application to skin or vaginal mucosa |
PCT/EP2009/062190 WO2010040632A1 (en) | 2008-10-08 | 2009-09-21 | Modified release emulsions for application to skin or vaginal mucosa |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201170555A1 true EA201170555A1 (ru) | 2011-12-30 |
Family
ID=40340663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201170555A EA201170555A1 (ru) | 2008-10-08 | 2009-09-21 | Эмульсии с модифицированным высвобождением для нанесения на кожные покровы или слизистую влагалища |
Country Status (19)
Country | Link |
---|---|
US (1) | US20110195944A1 (ru) |
EP (2) | EP2174650A1 (ru) |
JP (1) | JP2012505171A (ru) |
KR (1) | KR20110067115A (ru) |
CN (1) | CN102170862A (ru) |
AR (1) | AR073801A1 (ru) |
AU (1) | AU2009301275A1 (ru) |
BR (1) | BRPI0920565A2 (ru) |
CA (1) | CA2737255A1 (ru) |
CL (1) | CL2011000767A1 (ru) |
CO (1) | CO6361898A2 (ru) |
EA (1) | EA201170555A1 (ru) |
IL (1) | IL211681A0 (ru) |
MA (1) | MA32687B1 (ru) |
MX (1) | MX2011003696A (ru) |
NZ (1) | NZ591919A (ru) |
PE (1) | PE20110449A1 (ru) |
WO (1) | WO2010040632A1 (ru) |
ZA (1) | ZA201101818B (ru) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2612511T3 (es) * | 2011-01-27 | 2017-05-17 | Glaxosmithkline Biologicals Sa | Nanoemulsiones de adyuvante con inhibidores de cristalización |
KR20140024292A (ko) * | 2011-04-01 | 2014-02-28 | 유니버시티 오브 플로리다 리서치 파운데이션, 인크. | 치료제의 국소 전달용 감열성, 점막부착성 또는 표피부착성, 및 침투강화성 제제 |
DE102011076869A1 (de) * | 2011-06-01 | 2012-12-06 | Beiersdorf Ag | Emulsionszubereitungen mit verbesserten rheologischen Eigenschaften |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
ES2885523T3 (es) | 2011-11-23 | 2021-12-14 | Therapeuticsmd Inc | Formulaciones y terapias de reposición hormonal de combinación naturales |
CN104105472A (zh) | 2011-12-20 | 2014-10-15 | 维奥姆生物科学有限公司 | 用于治疗真菌感染的局部油组合物 |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
WO2014167554A2 (en) * | 2013-04-12 | 2014-10-16 | Vyome Biosciences Pvt. Ltd. | Composition and formulation of antimicrobial agents, processes thereof and methods for treating microbial infections |
MX2016011801A (es) * | 2014-03-12 | 2017-07-14 | Warner Chilcott Co Llc | Crema de estradiol de dosis baja. |
RU2016143081A (ru) | 2014-05-22 | 2018-06-26 | Терапьютиксмд, Инк. | Натуральные комбинированные гормонозаместительные составы и терапии |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
US9931349B2 (en) | 2016-04-01 | 2018-04-03 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
CA3040422A1 (en) * | 2016-10-13 | 2018-04-19 | Catalent U.K. Swindon Zydis Limited | Lyophilized pharmaceutical compositions for vaginal delivery |
JP7345398B2 (ja) * | 2017-06-22 | 2023-09-15 | ヴィラマル リミテッド | 薬物送達のための組成物およびその使用方法 |
WO2019213473A1 (en) | 2018-05-04 | 2019-11-07 | The Procter & Gamble Company | Compositions and methods for treating vaginal dryness |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60136648D1 (de) * | 2000-12-05 | 2009-01-02 | Los Angeles Childrens Hospital | Pharmazeutische zusammensetzungen von fenretinid mit erhöhter bioverfügbarkeit und verfahren zu deren verwendung |
AU2003218507A1 (en) * | 2002-04-04 | 2003-10-20 | Medicis Pharmaceutical Corporation | Methods for treating rosacea with pyridones |
US20060233721A1 (en) * | 2002-10-25 | 2006-10-19 | Foamix Ltd. | Foam containing unique oil globules |
US20060018937A1 (en) * | 2002-10-25 | 2006-01-26 | Foamix Ltd. | Steroid kit and foamable composition and uses thereof |
US20040087564A1 (en) * | 2002-10-31 | 2004-05-06 | Wright D. Craig | Delivery composition and method |
CA2611577A1 (en) * | 2005-06-07 | 2007-09-07 | Foamix Ltd. | Antibiotic kit and composition and uses thereof |
US20070071705A1 (en) * | 2005-09-29 | 2007-03-29 | De Oliveira Monica A M | Topical anti-microbial compositions |
US20080075745A1 (en) * | 2006-09-21 | 2008-03-27 | Glenmark Pharmaceuticals Limited | Topical pharmaceutical compositions containing ciclopirox or a pharmaceutically acceptable salt thereof |
-
2008
- 2008-10-08 EP EP08166058A patent/EP2174650A1/en not_active Withdrawn
-
2009
- 2009-09-21 PE PE2011000670A patent/PE20110449A1/es not_active Application Discontinuation
- 2009-09-21 WO PCT/EP2009/062190 patent/WO2010040632A1/en active Application Filing
- 2009-09-21 NZ NZ591919A patent/NZ591919A/xx not_active IP Right Cessation
- 2009-09-21 CA CA2737255A patent/CA2737255A1/en not_active Abandoned
- 2009-09-21 MX MX2011003696A patent/MX2011003696A/es unknown
- 2009-09-21 AU AU2009301275A patent/AU2009301275A1/en not_active Abandoned
- 2009-09-21 US US12/998,331 patent/US20110195944A1/en not_active Abandoned
- 2009-09-21 JP JP2011530445A patent/JP2012505171A/ja not_active Withdrawn
- 2009-09-21 BR BRPI0920565A patent/BRPI0920565A2/pt not_active IP Right Cessation
- 2009-09-21 EP EP09818802A patent/EP2331065A1/en not_active Withdrawn
- 2009-09-21 KR KR1020117007601A patent/KR20110067115A/ko not_active Application Discontinuation
- 2009-09-21 EA EA201170555A patent/EA201170555A1/ru unknown
- 2009-09-21 CN CN2009801391796A patent/CN102170862A/zh active Pending
- 2009-10-08 AR ARP090103886A patent/AR073801A1/es unknown
-
2011
- 2011-03-09 ZA ZA2011/01818A patent/ZA201101818B/en unknown
- 2011-03-10 IL IL211681A patent/IL211681A0/en unknown
- 2011-04-01 MA MA33736A patent/MA32687B1/fr unknown
- 2011-04-06 CL CL2011000767A patent/CL2011000767A1/es unknown
- 2011-04-07 CO CO11043013A patent/CO6361898A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP2174650A1 (en) | 2010-04-14 |
CA2737255A1 (en) | 2010-04-15 |
AU2009301275A2 (en) | 2011-04-28 |
NZ591919A (en) | 2012-09-28 |
IL211681A0 (en) | 2011-06-30 |
AU2009301275A1 (en) | 2010-04-15 |
US20110195944A1 (en) | 2011-08-11 |
JP2012505171A (ja) | 2012-03-01 |
CL2011000767A1 (es) | 2011-06-17 |
KR20110067115A (ko) | 2011-06-21 |
CN102170862A (zh) | 2011-08-31 |
MA32687B1 (fr) | 2011-10-02 |
EP2331065A1 (en) | 2011-06-15 |
CO6361898A2 (es) | 2012-01-20 |
MX2011003696A (es) | 2011-06-20 |
ZA201101818B (en) | 2012-05-30 |
WO2010040632A1 (en) | 2010-04-15 |
BRPI0920565A2 (pt) | 2015-12-29 |
AR073801A1 (es) | 2010-12-01 |
PE20110449A1 (es) | 2011-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201170555A1 (ru) | Эмульсии с модифицированным высвобождением для нанесения на кожные покровы или слизистую влагалища | |
CL2017003436A1 (es) | Compuestos de benzoxacepina oxazolidinona y métodos de uso | |
EA201101709A1 (ru) | Полициклические антагонисты рецепторов лизофосфатидной кислоты | |
PL3765088T3 (pl) | Transdermalne i/lub dermalne dostarczanie lipofilowych substancji czynnych | |
EA201100544A1 (ru) | Применение комбинации опиоидного агониста и конъюгата полимер-опиоидный антагонист для изготовления лекарственного средства для лечения и предупреждения боли | |
EA200802204A1 (ru) | Применение ингибиторов dpp iv | |
CL2012002356A1 (es) | Compuestos heterociclicos acidos derivados de ariltriazolonas ligadas a bisarilo, inhibidores de receptores de vasopresina v1a y v2; procedimiento de preparacion; composicion farmaceutica; y su uso para tratar y/o prevenir insuficiencia cardiaca aguda y cronica, hiponatremia, entre otras. | |
EA201390821A1 (ru) | Антагонисты рецепторов лизофосфатидной кислоты и их применение | |
DE602005016551D1 (de) | Stabilisierte supergesättigte feste lösungen von steroidalen arzneimitteln | |
TW200613004A (en) | External preparation of solid/oil type | |
BRPI0814851A2 (pt) | Combinações de substâncias ativas com propriedades inseticidsa e acaricidas | |
WO2010068281A3 (en) | Contact lens drug delivery device | |
EA201100691A1 (ru) | Антагонисты рецепторов лизофосфатидной кислоты | |
ECSP066684A (es) | Nitrooxiderivados de prostaglandinas | |
BRPI0809806A2 (pt) | "invólucro em membrana de um sistema de dosagem implantável e implante" | |
CY1124331T1 (el) | Αυξημενη βιοδιαθεσιμοτητα δραστικης ουσιας σε θεραπεια ναλτρεξονης | |
EP3513789A3 (en) | Prophylactic and therapeutic agents for fgfr3 diseases | |
WO2007106284A3 (en) | Silicone based emulsions for topical drug delivery | |
WO2011131765A3 (fr) | Emulsion lacrymimetique | |
EA201590797A1 (ru) | Препараты с модифицированным высвобождением опрозомиба | |
BRPI0910110A2 (pt) | Emulsões óleo-em-água estabilizadas incluindo ingredientes agricolamente ativos | |
NZ607103A (en) | A water-in-oil type emulsion for treating a disease of the eye | |
DE502007003630D1 (de) | Transdermales therapeutisches system mit ionenpaar-mikroreservoiren | |
CL2007002769A1 (es) | Compuestos derivados de sulfonamida; procedimiento de obtencion; composicion farmaceutica; y uso en el tratamiento de la diabetes. | |
BRPI0813279A2 (pt) | Uso de combinações de substâncias ativas com propriedades inseticidas para o combate de pragas animais da família dos percevejos catingosos |